全球結構生物學和分子建模技術市場：增長，趨勢，預測（2020-2025）

在預測期內，結構生物學和分子建模技術的市場規模預計將以約10.4％的複合年增長率增長。

• 推動市場增長的具體因素包括創新和進步，以及慢性病患病率的上升。
• 3D建模軟件是一個功能強大的工具，可以幫助許多專業人員創建複雜的3D圖形並可視化其工作。在結構生物學和生物化學領域，有各種用於分子建模和可視化的軟件。一些化學軟件擅長繪製化學反應，而另一些化學軟件在模擬蛋白質結構中發現了巨大的應用。

本報告調查了結構生物學和分子建模技術的全球市場，概述了市場，分析了市場增長和障礙，市場機會以及按工具，應用和地區劃分的市場規模趨勢和預測。它提供系統信息，例如競爭狀況和主要公司的概況。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

• 市場概況
• 市場驅動力
  • 技術創新與進步
  • 慢性病患病率上升
• 市場限制
  • 缺乏熟練的專業人員
• 波特的五力分析

第5章市場細分

• 通過工具
  • SaaS和獨立建模
  • 可視化和分析
  • 其他
• 按應用
  • 藥物開發
  • 藥物發現
  • 其他
• 按地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 南美洲

第6章競爭情況

• 公司簡介
  • Acellera Ltd
  • Agile Molecule
  • Agilent Technologies Inc.
  • Biomax Informatics AG
  • Bruker Daltonics Inc.
  • Chemical Computing Group
  • Dassault Systemes
  • Illumina
  • ThermoFisher Scientific

第7章 市場機會與動向

The structural biology and molecular modeling techniques market is anticipated to register a CAGR of nearly 10.4% during the forecast period.

• Certain factors that are driving the market growth include technological innovations and advancements and rising prevalence of chronic diseases.
• 3D modeling software is a powerful tool that helps many professionals create complex 3D graphics and visualize their work. In the field of structural biology and biochemistry, there are various software for molecular modeling and visualization. Some chemistry software are better in terms of drawing chemical reactions, and some others find better applications in the simulation of protein structures.

Key Market Trends

Drug Development Holds Significant Market Share in the Global Structural Biology and Molecular Modeling Techniques Market

The propelling factors for the growth of the drug discovery market include the rising prevalence of a wide range of diseases (such as cardiovascular and CNS-related disorders), rising healthcare expenditure, and upcoming patent expiration of blockbuster drugs.

The diverse range of diseases, primarily cardiovascular disease, infectious diseases, diabetes, and kidney-related complications, has a high prevalence, globally. Thus, the increasing prevalence of a diverse range of diseases among all age groups and its burden, globally, drives the demand for drug discovery and its market.

There has been an upsurge in the usage of advanced technologies, such as high throughput, bioinformatics, and combinatorial chemistry for better drug candidate identification.

North America Dominates the Global Structural Biology and Molecular Modeling Techniques Market

North America dominates the market and incurs the highest expenditure for global R&D. The United States accounted for the largest share in 2019. The North America segment is on a rise, due to various ongoing researches in biological sciences, considerable investments by various biotechnology companies, and the consistently increasing utilization of structural biology and molecular modeling techniques in the market. Owing to the ongoing research and outsourcing activities in the field of life science, Asia-Pacific also has lucrative opportunities for growth over the forecast period.

Competitive Landscape

The global structural biology and molecular modeling techniques market is competitive and consists of a number of major players. Companies, like Acellera Ltd, Agile Molecule, Agilent Technologies Inc., Biomax Informatics AG, Bruker Daltonics Inc., Chemical Computing Group, Dassault Systemes, Illumina, and ThermoFisher Scientific, hold the substantial market share in the market.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Technological Innovations and Advancements
  • 4.2.2 Rising Prevalence of Chronic Diseases
• 4.3 Market Restraints
  • 4.3.1 Lack of Skilled Professionals
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Tools
  • 5.1.1 SaaS and Standalone Modeling
    • 5.1.1.1 Homology Modeling
    • 5.1.1.2 Threading
    • 5.1.1.3 Molecular Dynamics
    • 5.1.1.4 Others
  • 5.1.2 Visualization and Analysis
  • 5.1.3 Other Tools
• 5.2 By Application
  • 5.2.1 Drug Development
  • 5.2.2 Drug Discovery
  • 5.2.3 Other Applications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Acellera Ltd
  • 6.1.2 Agile Molecule
  • 6.1.3 Agilent Technologies Inc.
  • 6.1.4 Biomax Informatics AG
  • 6.1.5 Bruker Daltonics Inc.
  • 6.1.6 Chemical Computing Group
  • 6.1.7 Dassault Systemes
  • 6.1.8 Illumina
  • 6.1.9 ThermoFisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS